"Factor VIIa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Activated form of factor VII. Factor VIIa activates factor X in the extrinsic pathway of blood coagulation.
| Descriptor ID |
D015942
|
| MeSH Number(s) |
D08.811.277.656.300.760.300 D08.811.277.656.959.350.300 D12.776.124.125.325.300 D23.119.325.300
|
| Concept/Terms |
Factor VIIa- Factor VIIa
- Coagulation Factor VIIa
- Factor VIIa, Coagulation
- Blood Coagulation Factor VII, Activated
- Factor VII, Activated
- Activated Factor VII
- Factor 7A
- Factor Seven A
|
Below are MeSH descriptors whose meaning is more general than "Factor VIIa".
Below are MeSH descriptors whose meaning is more specific than "Factor VIIa".
This graph shows the total number of publications written about "Factor VIIa" by people in this website by year, and whether "Factor VIIa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2017 | 2 | 2 | 4 |
| 2018 | 4 | 2 | 6 |
| 2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Factor VIIa" by people in Profiles.
-
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation. Thromb Haemost. 2019 Feb; 119(2):192-202.
-
Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients. Blood Coagul Fibrinolysis. 2019 Jan; 30(1):24-28.
-
Tissue factor (:Factor VIIa) in the heart and vasculature: More than an envelope. Thromb Res. 2018 08; 168:130-137.
-
In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis. Liver Int. 2018 11; 38(11):1988-1996.
-
Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on reversal agents. Int J Cardiol. 2018 Oct 01; 268:75-79.
-
The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptides. PLoS One. 2018; 13(5):e0197407.
-
Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model. Eur J Anaesthesiol. 2018 03; 35(3):208-214.
-
Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis. Arterioscler Thromb Vasc Biol. 2018 04; 38(4):709-725.
-
The pharmacokinetics and pharmacodynamics of single-dose and multiple-dose recombinant activated factor VII in patients with haemophilia A or B. Haemophilia. 2017 Nov; 23(6):868-876.
-
Management of pregnancy in type 3 von Willebrand disease with alloantibodies. Br J Haematol. 2018 08; 182(3):440-442.